Search - tctmd.com

Displaying 1 - 20 of 81

Sort: Relevancy | Date

Presentation TCT 2025

TCT 448: DeepRV: AI-Based Right Ventricular Function Assessment From Coronary Angiography

Presenter: Robert Avram

October 27, 2025

Presentation TCT 2025

TCT 894: Development and Internal Validation of an AI-Driven Model for 5-Year Cardiovascular Disease Risk Prediction in the Canadian Longitudinal Study on Aging : Comparative Performance vs. Traditional Risk Scores

Presenter: Robert Avram

October 27, 2025

Presentation TCT 2025

TCT 1336: Acquired Gerbode Defect Following Redo MVR/AVR

Presenter: Enhua Wang

October 27, 2025

Presentation TCT 2025

TCT 441: DeepCORO-CLIP: Development and Validation of a Foundation Model for Multi-view Coronary Artery Analysis Through Video-Text Contrastive Learning

Presenter: Robert Avram

October 26, 2025

Presentation TCT 2025

What Is Artificial Intelligence: Core Principles and Terminology

Presenter: Robert Avram

October 26, 2025

Presentation NY Valves 2025

AVR in Asymptomatic Severe Aortic Stenosis: The EARLY TAVR Trial and Beyond

Presenter: Brian R. Lindman

June 26, 2025

Presentation NY Valves 2025

Feasibility of Valve-in-Valve After TAVR: A Comparative Study of Sapien 3 vs. Surgical AVR

Presenter: Tej Sheth

June 26, 2025

Presentation NY Valves 2025

Late Health Status Outcomes with Patient-Prosthesis Mismatch After AVR in the PARTNER Trials

Presenter: Yasser M. Sammour

June 25, 2025

Presentation NY Valves 2025

Guideline Directed Indications and Consequences of Delayed AVR in Patients With Asymptomatic, Severe Aortic Stenosis: Results From the EARLY TAVR Trial

Presenter: Allan Schwartz

June 25, 2025

Presentation THT 2025

Lessons From AVR Studies in Patients With Aortic Stenosis and Heart Failure

Presenter: Nicolas Van Mieghem

February 12, 2025

Presentation TCT 2024

TCT 1220: Sequential PCI of a CTO LAD: Investment Procedure

Presenter: Jurij Avramovic

October 29, 2024

Presentation TCT 2024

TCT 1217: LM-LAD PCI in Subacute Anterior STEMI Complicated With Periprocedural Cardiac Arrest Supported With Novel pVAD

Presenter: Jurij Avramovic

October 28, 2024

Presentation NY Valves 2024

UPDATES: Pre-emptive AVR Clinical Trials for Moderate and Severe AS

Presenter: Philippe Pibarot

June 07, 2024

Presentation NY Valves 2024

Pre-emptive AVR for Moderate AS and Asymptomatic Severe AS: A Summary of Upcoming Trials

Presenter: Nicolas M. Van Mieghem

June 06, 2024

Presentation NY Valves 2024

Why Favor Redo SAVR After a Failed Bioprosthetic AVR?

Presenter: Tsuyoshi Kaneko

June 06, 2024

Presentation NY Valves 2024

Medical Management Post AVR

Presenter: Javed Butler

June 05, 2024

Presentation NY Valves 2024

Requirements for GDMT in UPSTREAM AVR Clinical Trials in (1) Preserved EF or (2) Reduced EF Patients

Presenter: Parag Goyal

June 05, 2024

Presentation CTO Plus 2024 Abstracts On-Demand 2024

Successful CTO LCX PCI with massive periprocedural cardiac tamponade

Presenter: Jurij Avramovic

February 02, 2024

$Novel pVAD-assisted complex CTO-PCI in a patient with reduced left ventricular ejection fraction$

Presentation CTO Plus 2024 Abstracts On-Demand 2024

Novel pVAD-assisted complex CTO-PCI in a patient with reduced left ventricular ejection fraction

Presenter: Jurij Avramovic

February 02, 2024

Presentation TCT 2023

I Have a Crystal Ball: What Will the AVR Universe Look Like in 2030?

Presenter: Bernard Prendergast

October 25, 2023

Advertisement

TCT 448: DeepRV: AI-Based Right Ventricular Function Assessment From Coronary Angiography

TCT 894: Development and Internal Validation of an AI-Driven Model for 5-Year Cardiovascular Disease Risk Prediction in the Canadian Longitudinal Study on Aging : Comparative Performance vs. Traditional Risk Scores

TCT 1336: Acquired Gerbode Defect Following Redo MVR/AVR

TCT 441: DeepCORO-CLIP: Development and Validation of a Foundation Model for Multi-view Coronary Artery Analysis Through Video-Text Contrastive Learning

What Is Artificial Intelligence: Core Principles and Terminology

AVR in Asymptomatic Severe Aortic Stenosis: The EARLY TAVR Trial and Beyond

Feasibility of Valve-in-Valve After TAVR: A Comparative Study of Sapien 3 vs. Surgical AVR

Late Health Status Outcomes with Patient-Prosthesis Mismatch After AVR in the PARTNER Trials

Guideline Directed Indications and Consequences of Delayed AVR in Patients With Asymptomatic, Severe Aortic Stenosis: Results From the EARLY TAVR Trial

Lessons From AVR Studies in Patients With Aortic Stenosis and Heart Failure

TCT 1220: Sequential PCI of a CTO LAD: Investment Procedure

TCT 1217: LM-LAD PCI in Subacute Anterior STEMI Complicated With Periprocedural Cardiac Arrest Supported With Novel pVAD

UPDATES: Pre-emptive AVR Clinical Trials for Moderate and Severe AS

Pre-emptive AVR for Moderate AS and Asymptomatic Severe AS: A Summary of Upcoming Trials

Why Favor Redo SAVR After a Failed Bioprosthetic AVR?

Medical Management Post AVR

Requirements for GDMT in UPSTREAM AVR Clinical Trials in (1) Preserved EF or (2) Reduced EF Patients

Successful CTO LCX PCI with massive periprocedural cardiac tamponade

Novel pVAD-assisted complex CTO-PCI in a patient with reduced left ventricular ejection fraction

I Have a Crystal Ball: What Will the AVR Universe Look Like in 2030?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content